Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,996 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enhancing lung transplantation with ECMO: a comprehensive review of mechanisms, outcomes, and future considerations.
Pervaiz Butt S, Kakar V, Abdulaziz S, Razzaq N, Saleem Y, Kumar A, Ashiq F, Ghisulal P, Thrush A, Malik S, Griffin M, Amir M, Khan U, Salim A, Zoumot Z, Mydin I, Aljabery Y, Bhatnagar G, Bayrak Y, Obeso A, Ahmed U. Pervaiz Butt S, et al. Among authors: griffin m. J Extra Corpor Technol. 2024 Dec;56(4):191-202. doi: 10.1051/ject/2024023. Epub 2024 Dec 20. J Extra Corpor Technol. 2024. PMID: 39705583 Free PMC article. Review.
Long-Term Efficacy and Safety of Danicopan as Add-On Therapy to Ravulizumab or Eculizumab in PNH With Significant EVH.
Kulasekararaj AG, Griffin M, Piatek CI, Shammo J, Nishimura JI, Patriquin CJ, Schrezenmeier H, Barcellini W, Panse JP, Gaya A, Patel Y, Liu P, Filippov G, Sicre de Fontbrune F, Risitano AM, Lee JW. Kulasekararaj AG, et al. Among authors: griffin m. Blood. 2024 Dec 19:blood.2024026299. doi: 10.1182/blood.2024026299. Online ahead of print. Blood. 2024. PMID: 39700502
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and associated with high response rates.
da Fonseca ARB, Justino CC, de Molla VC, Yamakawa PE, Rabelo IB, Arnold LM, Kelly RJ, Griffin M, Munir T, Hill A, Velloso EDRP, Dalessandro T, Risitano AM, Scheinberg P, Kulasekararaj AG, Arrais-Rodrigues C. da Fonseca ARB, et al. Among authors: griffin m. Blood Adv. 2024 Dec 18:bloodadvances.2024014159. doi: 10.1182/bloodadvances.2024014159. Online ahead of print. Blood Adv. 2024. PMID: 39693508
The Golden Age of Thermally Activated Delayed Fluorescence Materials: Design and Exploitation.
Dos Santos JM, Hall D, Basumatary B, Bryden M, Chen D, Choudhary P, Comerford T, Crovini E, Danos A, De J, Diesing S, Fatahi M, Griffin M, Gupta AK, Hafeez H, Hämmerling L, Hanover E, Haug J, Heil T, Karthik D, Kumar S, Lee O, Li H, Lucas F, Mackenzie CFR, Mariko A, Matulaitis T, Millward F, Olivier Y, Qi Q, Samuel IDW, Sharma N, Si C, Spierling L, Sudhakar P, Sun D, Tankelevičiu Tė E, Duarte Tonet M, Wang J, Wang T, Wu S, Xu Y, Zhang L, Zysman-Colman E. Dos Santos JM, et al. Among authors: griffin m. Chem Rev. 2024 Dec 12. doi: 10.1021/acs.chemrev.3c00755. Online ahead of print. Chem Rev. 2024. PMID: 39666979 Review.
Corneal Graft Rejection: Is it Reflected in Peripheral Immune Cells? Results of a Prospective Multicenter Study (VISICORT).
Vabres B, Pleyer U, Hjortdal J, Murphy CC, Armitage WJ, Imrie L, Cadoux M, Danger R, Bylesjo M, Mac Gabhann P, Tole D, Walkinshaw MD, Griffin MD, Brouard S, Degauque N. Vabres B, et al. Among authors: griffin md. Transplantation. 2024 Dec 12. doi: 10.1097/TP.0000000000005280. Online ahead of print. Transplantation. 2024. PMID: 39663555
Sickle Cell Retinopathy Lost to Follow-up Study.
Wong JCY, Sivalingam MD, Griffin M, Magagna J, Momenaei B, Wakabayashi T, Ni RL, Wang KY, Ammar MJ, Hsu J, Yonekawa Y. Wong JCY, et al. Among authors: griffin m. Retina. 2024 Dec 9. doi: 10.1097/IAE.0000000000004369. Online ahead of print. Retina. 2024. PMID: 39661943
2,996 results